Observational studyPaediatric drugs2024

The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model.

Susana Clemente-Bautista et al.PubMed ↗Publisher ↗

No numbers read from the abstract.